Study finds women with autoimmune conditions more likely to be told symptoms are psychological

Research shows women face longer waits for diagnosis and treatment compared to men

By LineZotpaper
Published
Updated
Read Time2 min
Sources2 outlets
Women with autoimmune conditions are up to 74% more likely than men to be told their symptoms are psychological or psychosomatic, and face longer waits for a diagnosis and treatment, according to a study by the University of Cambridge and the University of East Anglia, published in the Lancet eClinicalMedicine journal.

The research, which included more than 6,600 people with autoimmune conditions, most of whom were female and from the UK, suggests a stark gender divide in how doctors handle signs of these conditions. Women are more likely to have their conditions wrongly attributed to psychiatric causes, more likely to have symptoms misdiagnosed as psychosomatic, and more likely to experience delays in getting a diagnosis.

Lead author Melanie Sloan, a researcher in the department of public health and primary care at Cambridge and UEA, said the damage caused to women by these types of misdiagnosis can be very long lasting in terms of trusting doctors and their own self-esteem. She added that some women were forced to wait years before finally getting a diagnosis, causing long delays to treatment.

Among the conditions reported, almost a quarter of the women had autoimmune thyroid disease, which includes Hashimoto's disease and Graves' disease. One in seven women in the study had systemic lupus, which can cause tiredness, rashes and muscle pain. Among male patients, rheumatoid arthritis, vasculitis and antiphospholipid syndrome were the most common conditions.

§

Analysis

Why This Matters

  • The findings highlight a significant gender bias in healthcare that can lead to delayed treatment and worsened health outcomes for women with autoimmune conditions.
  • Misdiagnosis as psychological can erode trust between patients and doctors, with long-term effects on self-esteem and willingness to seek care.
  • With hundreds of millions of people affected by autoimmune conditions globally, addressing diagnostic disparities could improve quality of life for a large population.

Background

Autoimmune conditions occur when the immune system mistakenly attacks the body's own tissues, causing a range of symptoms including fatigue, muscle pain and rashes. They affect about one in 10 people worldwide. Previous research has suggested that women are more likely to be diagnosed with autoimmune diseases, but also that their symptoms are sometimes dismissed or attributed to mental health issues. This study provides quantitative evidence of the gap in how symptoms are interpreted based on gender.

Key Perspectives

Women patients: They report being told their physical symptoms are 'all in their head', leading to frustration, delayed diagnosis and prolonged suffering. The study's lead author noted the lasting damage to trust and self-esteem. Medical researchers: The study provides data to back up anecdotal reports of gender disparity, calling for greater awareness and training among clinicians to avoid misattributing symptoms to psychiatric causes without thorough investigation. Healthcare policymakers: The findings suggest a need for guidelines that explicitly address gender bias in diagnostic processes, particularly for autoimmune conditions where early intervention is crucial.

What to Watch

  • Further research into the specific mechanisms driving this gender bias and possible interventions.
  • Updates from medical bodies such as the NHS or Royal Colleges on training and guidelines to reduce diagnostic delays.
  • Public awareness campaigns that encourage women to persist in seeking second opinions if symptoms are dismissed.

Sources

Zotpaper

Written by software from the reporting listed above, scored by an automated standards desk, and published without a person reading it first. If something here is wrong, tell the editor and it will be put right.

How we workSubscribe